BRIEF published on 11/19/2025 at 15:50, 3 months 23 days ago The Vanguard Group Announces Shareholdings in Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Vanguard Group Shareholding Avadel Pharmaceuticals
BRIEF published on 11/19/2025 at 15:49, 3 months 23 days ago The Vanguard Group Discloses Position in Mural Oncology Form 8.3 Relevant Securities Irish Takeover Panel The Vanguard Group Mural Oncology
PRESS RELEASE published on 11/19/2025 at 15:48, 3 months 23 days ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses a 10.67% interest in Qualcomm Incorporated. Details of securities transactions provided in Form 8.3 filing Form 8.3 Disclosure Vanguard Group Securities Transactions Qualcomm
PRESS RELEASE published on 11/19/2025 at 15:47, 3 months 23 days ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses a 7.47% stake in American Axle & Manufacturing Holdings, Inc. as of 18 November 2025 Manufacturing Vanguard Group Financial Disclosure Stake American Axle
BRIEF published on 11/19/2025 at 15:47, 3 months 23 days ago The Vanguard Group Discloses Position in Dowlais Group plc Form 8.3 Takeover Code Vanguard Group Security Disclosure Dowlais Group
PRESS RELEASE published on 11/19/2025 at 15:45, 3 months 23 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses 5.71% stake in Avadel Pharmaceuticals plc as of 18 November 2025 Irish Takeover Panel Vanguard Group Financial Disclosure Stake Disclosure Avadel Pharmaceuticals
PRESS RELEASE published on 11/19/2025 at 15:44, 3 months 23 days ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses a 1.67% stake in Mural Oncology plc as per Form 8.3 submitted on 18 November 2025 The Vanguard Group, Inc. Form 8.3 Irish Takeover Panel Stake Disclosure Mural Oncology Plc
PRESS RELEASE published on 11/19/2025 at 15:42, 3 months 23 days ago Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc The Vanguard Group, Inc. discloses a 5.49% interest in Dowlais Group plc's 1p ordinary securities as of 18 November 2025 The Vanguard Group Interest Disclosure 1p Ordinary Securities 5.49% Interest Dowlais Group Plc
BRIEF published on 11/18/2025 at 15:40, 3 months 24 days ago The Vanguard Group Discloses Stake in Petershill Partners Takeover Code Securities Disclosure Vanguard Group Stock Transactions Petershill Partners
BRIEF published on 11/18/2025 at 15:39, 3 months 24 days ago Vanguard's Disclosure on Qualcomm Holdings Form 8.3 Takeover Code Securities Disclosure Vanguard Group Qualcomm Holdings
Published on 03/13/2026 at 00:30, 2 hours 41 minutes ago AI/ML Innovations Inc. Announces Proposed Private Placement of Convertible Debentures
Published on 03/12/2026 at 22:55, 4 hours 16 minutes ago Faraday Copper Reports 2025 Financial Results
Published on 03/12/2026 at 22:15, 4 hours 56 minutes ago Avidian Gold Announces the Appointment of a New Director
Published on 03/12/2026 at 22:00, 5 hours 11 minutes ago Onco-Innovations Announces Closing of Private Placement
Published on 03/12/2026 at 21:30, 5 hours 41 minutes ago Loop Industries to Attend the 38th Annual ROTH Conference, March 22-24, 2026
Published on 03/12/2026 at 23:59, 3 hours 12 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3C - Notice of daily buy back
Published on 03/12/2026 at 21:15, 5 hours 56 minutes ago Amrize Publishes Annual Report for Fiscal Year 2025
Published on 03/12/2026 at 18:45, 8 hours 25 minutes ago Swiss Prime Site: Annual General Meeting approves all proposals of the Board of Directors by a large majority
Published on 03/12/2026 at 18:30, 8 hours 41 minutes ago FIERA MILANO: THE BOARD OF DIRECTORS APPROVES THE CONSOLIDATED RESULTS AS OF 31 DECEMBER 2025
Published on 03/12/2026 at 18:00, 9 hours 11 minutes ago NEW OR RENEWED AGREEMENTS BETWEEN EURAZEO AND CERTAIN FAMILY SHAREHOLDERS
Published on 03/12/2026 at 15:06, 12 hours 4 minutes ago FIERA MILANO: THE BOARD OF DIRECTORS APPROVES THE CONSOLIDATED RESULTS AS OF 31 DECEMBER 2025
Published on 03/12/2026 at 10:55, 16 hours 15 minutes ago Statement of transactions in own shares on March 9th, 2026
Published on 03/12/2026 at 07:30, 19 hours 41 minutes ago Biophytis-LynxKite Alliance Expands to Turbocharge AI-driven drug discovery for next generation longevity therapeutics
Published on 03/11/2026 at 18:30, 1 day 8 hours ago Filing of the 2025 TF1 Universal Registration Document
